|
|
|
August 10, 2026 · Weekly Newsletter
Good morning, Reader.
This week, we see a striking contradiction in how we support patients. While a new study on **Emotional support after cancer: What works for young adults?** highlights the profound emotional and financial strain faced by cancer patients, other data show a persistent reliance on pharmacologic solutions even when behavioral interventions or simpler options exist. We are still not addressing the whole patient effectively.
1. **Patient Burden**, Gastric and GEJ adenocarcinomas cause severe physical symptoms, emotional strain, and financial burdens. These impacts change identity and relationships. That matters.
2. **Oral vs. IV Antibiotics**, Oral antibiotics are non-inferior to IV regimens for severe community-acquired bacterial pneumonia in children. This challenges traditional practice.
3. **Coffee and Liver Health**, Regular coffee consumption correlates with a reduced risk of chronic liver disease and associated mortality, according to UK Biobank data. This is a simple, accessible intervention.
The pattern here is clear: we are still struggling to integrate comprehensive patient care with targeted medical interventions. There is a disconnect between recognizing the full scope of patient suffering and consistently deploying non-pharmacological or lifestyle-based strategies.
Clinicians must consider the full spectrum of patient needs, not just the immediately treatable disease.
I read every reply.
|
|
|
|
Solid Tumors
Gastric or gastroesophageal junction (GEJ) adenocarcinomas are aggressive cancers, often spreading quickly to nearby lymph nodes. Patients with these cancers face not only severe physical symptoms like pain, fatigue, and difficulty eating, but also profound emotional strain, challenges with daily activities, and significant financial burdens from treatment and travel. These impacts extend to changes in their sense of identity and relationships, highlighting a critical need for comprehensive…
Continue Reading →
|
|
|
|
Congress Coverage
Follow the science, live.
Real-time coverage from leading medical congresses: summaries, key data, and expert commentary.
|
|
Aug 28 – 31, 2026 · Munich
Messe München, Am Messesee 2, 81829 München, Germany
ESC 2026: ESC 2026
View Coverage →
|
|
|
Sep 5 – 9, 2026 · Barcelona
Fira Gran Via (Halls 1 to 3), Carrer de les Ciències, s/n, Hospitalet de Llobregat, 08908 Barcelona
ERS 2026: ERS International Congress 2026
View Coverage →
|
|
|
Sep 28 – Oct 2, 2026 · Milan
Allianz MiCo - Milan Convention Centre
EASD 2026: EASD Annual Meeting 2026
View Coverage →
|
|
|
|
Podcast Spotlight
CAR-T & the Future of Blood Cancer Debate Series · EP 1
|
Listen Now →
|
|
|
| |
|
Special Reports
|
LSF Intelligence Series
|
LSF Special Reports
In-depth briefings from the LSF Intelligence Series, co-authored by Mara Voss and the LSF Editorial Team. Each report covers the trial data, the clinical context, and what it means in practice.
|
|
|
|
Intended Audience
This publication is intended for healthcare professionals, researchers, and life science industry professionals. Content is provided for informational and educational purposes only and does not constitute medical advice.
Press Credentials
The Life Science Feed holds accredited press credentials for major international medical and scientific congresses across cardiology, oncology, pulmonology, neurology, rheumatology, and more.
View our press accreditations →
© 2025–2026 The Life Science Feed. All rights reserved.
A digital publication from Grá & Mawi Media Co.
LSF-MY82HK-NL-GEN-W3326
You are receiving this because you subscribed at
thelifesciencefeed.com.
Under GDPR, you have the right to access, correct, or delete your personal data at any time.
|
|
|